Kraig Biocraft Laboratories, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 3.03 million compared to USD 3.84 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1173 USD | -7.46% | +16.14% | +203.10% |
05-09 | Kraig Biocraft Laboratories, Inc. Spring Spider Silk Production Trials Exceed Expectations | CI |
04-29 | Kraig Biocraft Laboratories, Inc. Reports Signing Agreements in South East Asia | CI |
1st Jan change | Capi. | |
---|---|---|
+203.10% | 132M | |
+16.74% | 66.18B | |
+1.83% | 49.24B | |
+16.59% | 41.72B | |
+22.44% | 26.16B | |
+12.85% | 19.75B | |
+3.05% | 17.5B | |
-23.54% | 15.63B | |
-6.12% | 15.46B | |
+2.67% | 15.43B |
- Stock Market
- Equities
- KBLB Stock
- News Kraig Biocraft Laboratories, Inc.
- Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023